Press Releases

News Brief

Samsung Biologics invites WHO program trainees for biologics development and manufacturing training

Samsung Biologics invites WHO program trainees for biologics development and manufacturing training 

  

Samsung Biologics hosted representatives from the World Health Organization's human resource training hub to offer an introductory course on biologics development and manufacturing. About 40 trainees and staffs toured the company’s biomanufacturing facilities to learn about the production process involved in vaccine and biopharmaceutical manufacturing and quality control. Samsung Biologics has taken part in the training program since last year after the WHO designated Korea as a “Global Biomanufacturing Training Hub” to serve low- and middle-income countries seeking to produce biologics. The company is committed to building a strong bio community by fostering both local and global experts to drive innovation and encourage growth.
 

Samsung Biologics invites WHO program trainees for biologics development and manufacturing training 

 

Samsung Biologics hosted representatives from the World Health Organization's human resource training hub to offer an introductory course on biologics development and manufacturing. About 40 trainees and staffs toured the company’s biomanufacturing facilities to learn about the production process involved in vaccine and biopharmaceutical manufacturing and quality control. Samsung Biologics has taken part in the training program since last year after the WHO designated Korea as a “Global Biomanufacturing Training Hub” to serve low- and middle-income countries seeking to produce biologics. The company is committed to building a strong bio community by fostering both local and global experts to drive innovation and encourage growth. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION